![](https://webarchive.library.unt.edu/eot2008/20090509190003im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090509190003im_/http://www.cancer.gov/images/spacer.gif)
dihydro-5-azacytidine A synthetic nucleoside analogue of deoxycytidine. Dihydro-5-azacytidine inhibits DNA methyltransferase, thereby interfering with abnormal DNA methylation patterns that are associated with genetic instability in some tumor cells. Inhibition of this enzyme may restore expression of tumor-suppressor genes and result in antitumor activity. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
![](https://webarchive.library.unt.edu/eot2008/20090509190003im_/http://www.cancer.gov/images/spacer.gif)
Abbreviation: | ![](https://webarchive.library.unt.edu/eot2008/20090509190003im_/http://www.cancer.gov/images/spacer.gif) | DHAC | | ![](https://webarchive.library.unt.edu/eot2008/20090509190003im_/http://www.cancer.gov/images/spacer.gif) | Chemical structure names: | ![](https://webarchive.library.unt.edu/eot2008/20090509190003im_/http://www.cancer.gov/images/spacer.gif) | - 1,3,5-triazin-2(1H)-one, 4-amino-3, 6-dihydro-1-beta-D-ribofuranosyl monohydrochloride
- 5,6-dihydro-5-azacytidine HCl
- 5,6-dihydro-5-azacytidine hydrochloride
| | ![](https://webarchive.library.unt.edu/eot2008/20090509190003im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20090509190003im_/http://www.cancer.gov/images/spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20090509190003im_/http://www.cancer.gov/images/gray_spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20090509190003im_/http://www.cancer.gov/images/spacer.gif)
|
![](https://webarchive.library.unt.edu/eot2008/20090509190003im_/http://www.cancer.gov/images/spacer.gif) |